Role of decreased circulating hepcidin concentrations in the iron excess of women with the polycystic ovary syndrome

Journal of Clinical Endocrinology and Metabolism

Volumn 96, Issue 3, 2011, Pages 846-852

  Luque Ramírez, Manuel ^a   Álvarez Blasco, Francisco ^a   Alpañés, Macarena ^a   Escobar Morreale, Héctor F ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIANDROGEN; FERRITIN; HEPCIDIN; IRON; METFORMIN; TESTOSTERONE;

ADULT; ARTICLE; BODY MASS; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FERRITIN BLOOD LEVEL; HORMONAL REGULATION; HORMONE BLOOD LEVEL; HORMONE RESPONSE; HUMAN; INSULIN RELEASE; IRON OVERLOAD; MENSTRUAL CYCLE; OLIGOMENORRHEA; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; TESTOSTERONE BLOOD LEVEL; WAIST CIRCUMFERENCE;

ADULT; ANDROGEN ANTAGONISTS; ANTHROPOMETRY; ANTIMICROBIAL CATIONIC PEPTIDES; CASE-CONTROL STUDIES; FEMALE; FERRITINS; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN RESISTANCE; IRON; IRON OVERLOAD; LINEAR MODELS; MENSTRUATION; METFORMIN; POLYCYSTIC OVARY SYNDROME; TIME FACTORS; YOUNG ADULT;

EID: 79952303397     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2010-2211     Document Type: Article

References (26)

1. Escobar-Morreale HF, Luque-Ramírez M, Álvarez-Blasco F, Botella-Carretero JI, Sancho J, San Millán JL 2005 Body iron stores are increased in overweight and obese women with polycystic ovary syndrome. Diabetes Care 28:2042-2044 (Pubitemid 41060986)
2. Martínez-García MA, Luque-Ramírez M, San-Millán JL, Escobar-Morreale HF 2009 Body iron stores and glucose intolerance in premenopausal women: role of hyperandrogenism, insulin resistance, and genomic variants related to inflammation, oxidative stress, and iron metabolism. Diabetes Care 32:1525-1530
3. Fernández-Real JM, López-Bermejo A, Ricart W 2002 Cross-talk between iron metabolism and diabetes. Diabetes 51:2348-2354 (Pubitemid 34827381)
4. Sheu WH, Chen YT, Lee WJ, Wang CW, Lin LY 2003 A relationship between serum ferritin and the insulin resistance syndrome is present in non-diabeticwomenbut not in non-diabetic men. Clin Endocrinol (Oxf) 58:380-385 (Pubitemid 36308128)
5. Luque-Ramírez M, Alvarez-Blasco F, Botella-Carretero JI, Sanchón R, San Millán JL, Escobar-Morreale HF 2007 The increased body iron stores of obese women with polycystic ovary syndrome are a consequence of insulin resistance and hyperinsulinism, and do not result from reduced menstrual losses. Diabetes Care 30:2309-2313 (Pubitemid 47359039)
6. Nemeth E, Tuttle MS, Powelson J, Vaughn MB, Donovan A, Ward DM, Ganz T, Kaplan J 2004 Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 306:2090-2093 (Pubitemid 40007660)
7. Roetto A, Papanikolaou G, Politou M, Alberti F, Girelli D, Christakis J, Loukopoulos D, Camaschella C 2003 Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis. Nat Genet 33:21-22 (Pubitemid 36068676)
8. Nicolas G, Bennoun M, Porteu A, Mativet S, Beaumont C, Grandchamp B, Sirito M, Sawadogo M, Kahn A, Vaulont S 2002 Severe iron deficiency anemia in transgenic mice expressing liver hepcidin. Proc Natl Acad Sci USA 99:4596-4601 (Pubitemid 34286030)
9. Fernández-Real JM, Equitani F, Moreno JM, Manco M, Ortega F, Ricart W 2009 Study of circulating prohepcidin in association with insulin sensitivity and changing iron stores. J Clin Endocrinol Metab 94:982-988
10. Le Guenno G, Chanséaume E, Ruivard M, Morio B, Mazur A 2007 Study of iron metabolism disturbances in an animal model of insulin resistance. Diabetes Res Clin Pract 77:363-370 (Pubitemid 47211345)
11. Piperno A, Girelli D, Nemeth E, Trombini P, Bozzini C, Poggiali E, Phung Y, Ganz T, Camaschella C 2007 Blunted hepcidin response to oral iron challenge in HFE-related hemochromatosis. Blood 110:4096-4100 (Pubitemid 350248467)
12. van Dijk BA, Laarakkers CM, Klaver SM, Jacobs EM, van Tits LJ, Janssen MC, Swinkels DW 2008 Serum hepcidin levels are innately low in HFE-related haemochromatosis but differ between C282Y-homozygotes with elevated and normal ferritin levels. Br J Haematol 142:979-985
13. Luque-Ramírez M, Alvarez-Blasco F, Botella-Carretero JI, Martínez-Bermejo E, Lasunción MA, Escobar-Morreale HF 2007 Comparison of ethinyl-estradiol plus cyproterone acetate versus metformin effects on classic metabolic cardiovascular risk factors in women with the polycystic ovary syndrome. J Clin Endocrinol Metab 92:2453-2461 (Pubitemid 47037342)
14. Zawadzki JK, Dunaif A 1992 Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. In: Dunaif A, Givens JR, Haseltine FP, Merriam GR, eds. Polycystic ovary syndrome. Boston: Blackwell Scientific Publications; 377-384
15. Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Futterweit W, Janssen OE, Legro RS, Norman RJ, Taylor AE, Witchel SF 2006 Position statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. J Clin Endocrinol Metab 91:4237-4245 (Pubitemid 44833391)
16. Escobar-Morreale HF, Sanchón R, San Millán JL 2008 A prospective study of the prevalence of nonclassic congenital adrenal hyperplasia (NCAH) among women presenting hyperandrogenic symptoms and signs. J Clin Endocrinol Metab 93:527-533 (Pubitemid 351240826)
17. Matsuda M, DeFronzo RA 1999 Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22:1462-1470 (Pubitemid 29418240)
18. Tai MM 1994 A mathematical model for the determination of total area under glucose tolerance and other metabolic curves. Diabetes Care 17:152-154 (Pubitemid 24035313)
19. McCarty MF 2003 Hyperinsulinemia may boost both hematocrit and iron absorption by upregulating activity of hypoxia-inducible factor-1α. Med Hypotheses 61:567-573 (Pubitemid 37411901)
20. Minamiyama Y, Takemura S, Kodai S, Shinkawa H, Tsukioka T, Ichikawa H, Naito Y, Yoshikawa T, Okada S 2010 Iron restriction improves type 2 diabetes mellitus in Otsuka Long-Evans Tokushima fatty rats. Am J Physiol Endocrinol Metab 298:E1140-E1149
21. Lin L, Valore EV, Nemeth E, Goodnough JB, Gabayan V, Ganz T 2007 Iron transferrin regulates hepcidin synthesis in primary hepatocyte culture through hemojuvelin and BMP2/4. Blood 110:2182-2189 (Pubitemid 47443938)
22. Ganz T, Olbina G, Girelli D, Nemeth E, Westerman M 2008 Immunoassay for human serum hepcidin. Blood 112:4292-4297
23. Bachman E, Feng R, Travison T, Li M, Olbina G, Ostland V, Ulloor J, Zhang A, Basaria S, Ganz T, Westerman M, Bhasin S 2010 Testosterone suppresses hepcidin in men: a potential mechanism for testosterone-induced erythrocytosis. J Clin Endocrinol Metab 95:4743-4747
24. Robinson S, Kiddy D, Gelding SV, Willis D, Niththyananthan R, Bush A, Johnston DG, Franks S 1993 The relationship of insulin insensitivity to menstrual pattern in women with hyperandrogenism and polycystic ovaries. Clin Endocrinol (Oxf) 39:351-355 (Pubitemid 23274435)
25. Legro RS, Bentley-Lewis R, Driscoll D, Wang SC, Dunaif A 2002 Insulin resistance in the sisters of women with polycystic ovary syndrome: association with hyperandrogenemia rather than menstrual irregularity. J Clin Endocrinol Metab 87:2128-2133 (Pubitemid 34521498)
26. Piperno A, Mariani R, Trombini P, Girelli D 2009 Hepcidin modulation in human diseases: from research to clinic. World J Gastroenterol 15:538-551